Mepron and Vitreous detachment - a phase IV clinical study of FDA data

Summary:

Vitreous detachment is reported as a side effect among people who take Mepron (atovaquone), especially for people who are female, 50-59 old, also take Flagyl, and have Osteoporosis.

The phase IV clinical study analyzes which people have Vitreous detachment when taking Mepron. It is created by eHealthMe based on reports of 2,035 people who have side effects when taking Mepron from the FDA, and is updated regularly.

What is Mepron?

Mepron has active ingredients of atovaquone. It is often used in babesiosis. eHealthMe is studying from 2,091 Mepron users. Check the latest studies of Mepron.

What is Vitreous detachment?

Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina) is found to be associated with 412 drugs and 457 conditions by eHealthMe. Check the latest studies of Vitreous detachment.

On Jul, 17, 2026

2,035 people reported to have side effects when taking Mepron.
Among them, 25 people (1.23%) have Vitreous detachment.

Among these 25 people:

What is the gender of people who have Vitreous detachment when taking Mepron? *

female: 100 %
male: 0.0 %

What is the age of people who have Vitreous detachment when taking Mepron? *

What are other drugs people take besides Mepron? *

What are other side effects people have besides Vitreous detachment? *

Wound Infection Staphylococcal: 25 people, 100.00%
Osteolysis (dissolution of bone): 25 people, 100.00%
Enteritis (inflammation of the small intestine): 25 people, 100.00%
Diarrhea: 25 people, 100.00%
Oedema Peripheral (superficial swelling): 25 people, 100.00%
Dental Caries: 25 people, 100.00%
Osteitis (a general term for inflammation of bone): 25 people, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 25 people, 100.00%
Osteomyelitis (infection of bone): 25 people, 100.00%
Mouth Ulcers: 25 people, 100.00%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 25 people, 100.00%
Osteoporosis (bones weak and more likely to break): 25 people, 100.00%
Thrombocytopenia (decrease of platelets in blood): 11 people, 44.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mepron and have Vitreous detachment?

- Check whether Vitreous detachment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mepron:

Mepron (2,091 reports)

Browse all side effects of Mepron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitreous detachment:

Vitreous detachment (412 drugs)

Browse all the conditions that are associated with Vitreous detachment:

Vitreous detachment (457 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atovaquone (the active ingredients of Mepron) and Mepron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.